Abhijeet Waghray, MD
Internal Medicine · Boston, MANPI 1073878351
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 563 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 28.9% of the total. Reporting peaked in 2022 at $4,409 and has fallen 96.4% since, to $161 in 2024. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 563 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- E.r. Squibb & Sons, L.L.C.$1K
- Johnson & Johnson$598
- Redhill Biopharma Inc.$571
- Takeda Pharmaceuticals U.S.A., Inc.$556
- plus $3K from 24 others
What the payments were for
- Speaking & faculty fees$230%
- Food & beverage$12,88698%
- Education$1781%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 133 | $3,788 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 196 | $3,002 |
| E.r. Squibb & Sons, L.L.C. | 10 | $1,123 |
| Johnson & Johnson | 24 | $598 |
| Redhill Biopharma Inc. | 34 | $571 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $556 |
| Ferring Pharmaceuticals Inc. | 15 | $471 |
| QOL Medical, LLC | 15 | $417 |
| Pfizer | 14 | $355 |
| Regeneron Healthcare Solutions, Inc. | 12 | $345 |
| Merck | 14 | $297 |
| Boston Scientific | 2 | $249 |
| Bristol Myers Squibb | 16 | $236 |
| Romark Laboratories, LC | 2 | $144 |
| Sanofi | 6 | $137 |
| Daiichi Sankyo Inc. | 5 | $128 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| Vivus LLC | 5 | $92 |
| Intercept Pharmaceuticals, Inc. | 4 | $87 |
| Nestle Healthcare Nutrition Inc. | 3 | $67 |
| Blueprint Medicines Corporation | 2 | $63 |
| Gilead | 2 | $42 |
| Capsovision, Inc. | 2 | $37 |
| Ironwood Pharmaceuticals, Inc | 2 | $35 |
| Braintree Laboratories, Inc. | 2 | $30 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Napo Pharmaceuticals Inc | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $15 |
| Micro-tech Endoscopy USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPOSIA$934
- TRULANCE$479
- Skyrizi$410
- Alinia$369
- Talicia$150
- Apollo ESG NXT System$146
- Humira$144
- DUPIXENT$125
- STELARA$121
- EXALT Model D$102
How this compares
$13,087 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 39 | $704 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 26 | $537 |
| Omeprazole | 47 | $390 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Boston
- David SchenkeinBoston$5M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
- Daniel KuritzkesBoston$443K
- Xiuning leBoston$364K
- Nancy GaglianoBoston$358K
- Fatima StanfordBoston$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.